fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Triptorelin pamoate

All strengths: General benefit; same patient cost rules

Shared coverage and patient cost rules
StatusGeneral benefit
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription

Trelstar (1 Month) · DIN 02240000 · 3.75 mg/Vial · powder for injection, vial

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
No interchangeable product listed in the Ontario extract
Trelstar (1 Month) · DIN 02240000 Manufacturer: Knight Therapeutics Inc.; listing date 2007-01-02 Health Canada: Marketed since 2020-09-08 · brand TRELSTAR · ATC L02AE04 TRIPTORELIN · form Powder for suspension (sustained-release · route Intramuscular · ingredients TRIPTORELIN (TRIPTORELIN PAMOATE) 3.75 MG/VIAL · company Knight therapeutics inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Trelstar (1 Month): Formulary list price $346.31 per unit (the source does not state the unit; exact figure $346.3100). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02240000)

Source record
DIN 02240000: Trelstar (1 Month) Raw flags: sec3=Y Item: 100000186; group id 188; item number 0344; lccId None; manufacturer id KNT Source form: Inj Pd-Vial Pk; strength: 3.75mg/Vial Recorded listing: General benefit Source prices (unrounded): $346.3100; ministry $346.3100 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02240000 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63507
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02240000
Shortage record checked October 6, 2026

Trelstar LA (3 Month) · DIN 02243856 · 11.25 mg/Vial · powder for injection, vial

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
No interchangeable product listed in the Ontario extract
Trelstar LA (3 Month) · DIN 02243856 Manufacturer: Knight Therapeutics Inc.; listing date 2007-01-02 Health Canada: Marketed since 2020-09-14 · brand TRELSTAR · ATC L02AE04 TRIPTORELIN · form Powder for suspension (sustained-release · route Intramuscular · ingredients TRIPTORELIN (TRIPTORELIN PAMOATE) 11.25 MG/VIAL · company Knight therapeutics inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Trelstar LA (3 Month): Formulary list price $1038.97 per unit (the source does not state the unit; exact figure $1038.9700). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02243856)

Source record
DIN 02243856: Trelstar LA (3 Month) Raw flags: sec3=Y Item: 100000187; group id 188; item number 0345; lccId None; manufacturer id KNT Source form: Inj Pd-Vial Pk; strength: 11.25mg/Vial Recorded listing: General benefit Source prices (unrounded): $1038.9700; ministry $1038.9700 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02243856 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=67797
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02243856
Shortage record checked October 6, 2026

Trelstar · DIN 02412322 · 22.5 mg/Vial · extended release injection Pd with Sterile Water-vial

General benefitMarketed · checked November 19, 2026
Write on scriptno code needed
No interchangeable product listed in the Ontario extract
Trelstar · DIN 02412322 Manufacturer: Knight Therapeutics Inc.; listing date 2014-10-29 Health Canada: Marketed since 2020-10-14 · brand TRELSTAR · ATC L02AE04 TRIPTORELIN · form Powder for suspension (sustained-release · route Intramuscular · ingredients TRIPTORELIN (TRIPTORELIN PAMOATE) 22.5 MG/VIAL · company Knight therapeutics inc. · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Trelstar: Formulary list price $1659.90 per unit (the source does not state the unit; exact figure $1659.9000). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02412322)

Source record
DIN 02412322: Trelstar Raw flags: sec3=Y Item: 100000240; group id 188; item number 0346; lccId None; manufacturer id KNT Source form: SR Inj Pd with Sterile Water-Vial Pk; strength: 22.5mg/Vial Recorded listing: General benefit Source prices (unrounded): $1659.9000; ministry $1659.9000 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02412322 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89690
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02412322
Shortage record checked October 6, 2026

Trelstar (1 Month) · PIN 09857199 · 3.75 mg/Vial · injection Pd with Sterile Water-vial

General benefitOntario PIN; no Health Canada record under this code
Write on scriptno code needed

No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp

Check Health Canada brand search
No interchangeable product listed in the Ontario extract
Trelstar (1 Month) · DIN 09857199 Manufacturer: Knight Therapeutics Inc.; listing date 2007-01-02 No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)

Trelstar (1 Month): Formulary list price $346.31 per unit (the source does not state the unit; exact figure $346.3100). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09857199)

Source record
DIN 09857199: Trelstar (1 Month) Raw flags: sec3=Y Item: 100000188; group id 188; item number 0342; lccId None; manufacturer id KNT Source form: Inj Pd with Sterile Water-Vial Pk; strength: 3.75mg/Vial Recorded listing: General benefit Source prices (unrounded): $346.3100; ministry $346.3100 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09857199 Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=09857199
Shortage record checked October 6, 2026

Trelstar LA (3 Month) · PIN 09857200 · 11.25 mg/Vial · injection Pd with Sterile Water-vial

General benefitOntario PIN; no Health Canada record under this code
Write on scriptno code needed

No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp

Check Health Canada brand search
No interchangeable product listed in the Ontario extract
Trelstar LA (3 Month) · DIN 09857200 Manufacturer: Knight Therapeutics Inc.; listing date 2007-01-02 No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)

Trelstar LA (3 Month): Formulary list price $1038.97 per unit (the source does not state the unit; exact figure $1038.9700). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09857200)

Source record
DIN 09857200: Trelstar LA (3 Month) Raw flags: sec3=Y Item: 100000189; group id 188; item number 0343; lccId None; manufacturer id KNT Source form: Inj Pd with Sterile Water-Vial Pk; strength: 11.25mg/Vial Recorded listing: General benefit Source prices (unrounded): $1038.9700; ministry $1038.9700 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09857200 Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=09857200
Shortage record checked October 6, 2026

Other products in the same Health Canada class (L02A, L02AE): coverage varies; not interchangeable

  • Buserelin (Suprefact Depot 2 Months): general benefit
  • Goserelin (Zoladex): general benefit
  • Leuprolide (Lupron Depot PDS): general benefit
  • Megestrol (Megace): general benefit, not a benefit
Other drugs in the same formulary class (10:00 ANTINEOPLASTIC AGENTS) and how they are covered

Matched class: 10:00 ANTINEOPLASTIC AGENTS

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Public program routes: ODB 65 and over Covered without a code on the Ontario formulary: ABIRATERONE ACETATE, ALTRETAMINE, ANASTROZOLE, BUSERELIN ACETATE, BUSULFAN, CAPECITABINE, CHLORAMBUCIL, CYPROTERONE ACETATE, DAUNORUBICIN, DEGARELIX ACETATE, ETOPOSIDE, EXEMESTANE, FLUOROURACIL & SALICYLIC ACID, FULVESTRANT, GOSERELIN ACETATE, HYDROXYUREA, IMATINIB MESYLATE, LETROZOLE, LEUPROLIDE ACETATE, MELPHALAN, MERCAPTOPURINE, MITOTANE, PROCARBAZINE HCL, TEMOZOLOMIDE, THIOGUANINE Some products covered without a code (check the product listing): BICALUTAMIDE, CYCLOPHOSPHAMIDE, FLUTAMIDE, LOMUSTINE (CCNU), MEGESTROL ACETATE, METHOTREXATE, TAMOXIFEN CITRATE, VINCRISTINE SULFATE 10:00 ANTINEOPLASTIC AGENTS

BUSERELIN ACETATE

· 4 products · General benefit · strengths: 6.3mg, 9.45mg, 1mg/mL · Implant Kit, Inj Sol-5.5mL Pk, Nas Sp-10mL Pk

GOSERELIN ACETATE

· 2 products · General benefit · strengths: 3.6mg, 10.8mg · Depot Inj

LEUPROLIDE ACETATE

· 11 products · General benefit · strengths: 3.75mg, 7.5mg, 11.25mg, 22.5mg, 30mg, 3.75mg/Vial, 22.5mg/Vial, 45mg · Inj-Kit, Pd for Inj - Vial Pk, Pd Susp Inj-Pref Syr Kit

MEGESTROL ACETATE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 40mg, 160mg · Tab

ABIRATERONE ACETATE

· 18 products · General benefit · strengths: 250mg, 500mg · Tab

ALTRETAMINE

· 1 products · General benefit · strengths: 50mg · Cap

ANASTROZOLE

· 18 products · General benefit · strengths: 1mg · Tab

BICALUTAMIDE

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 50mg · Tab

BUSULFAN

· 1 products · General benefit · strengths: 2mg · Tab

CAPECITABINE

· 15 products · General benefit · strengths: 150mg, 500mg · Tab

CHLORAMBUCIL

· 1 products · General benefit · strengths: 2mg · Tab

CYCLOPHOSPHAMIDE

· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 25mg, 50mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 10:00 and 34 more
Full class listing Related classes: Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 Indications TRELSTAR (triptorelin for injectable suspension) is indicated for: • The management and relief of chronic pain associated with endometriosis. • The palliative treatment of hormone dependent advanced carcinoma of the prostate gland (stage D2). For the management and relief of chronic pain in endometriosis, experience in women has been limited to women 18 years of age or older treated for 6 months. 1.1 Pediatrics Pediatrics (< 18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use (see 7.1.3 Pediatrics). 1.2 Geriatrics Geriatrics (≥ 65 years of age): No data are available to Health Canada for the management and relief of chronic pain associated with endometriosis in geriatric patients. The majority of the patients studied in the clinical trials for the palliative treatment of prostate cancer with TRELSTAR were 65 years and older (see 14 Clinical Trials). https://pdf.hres.ca/dpd_pm/00085331.PDF PM date: 2026-07-14 Source product: TRELSTAR; DIN 02240000; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.
Program rules and quotes
Public program routes (Ontario context; residency, health-card/OHIP requirements and enrolment must be confirmed from the quoted rules): ODB 65 and over (seniors path) Eligibility: You may qualify for the Ontario Drug Benefit (ODB) program when you turn 65 years old. (ontario.ca, August 18, 2026 ↗) Eligibility: The Ontario Drug Benefit program is for Ontario residents only and prescriptions must be filled in an Ontario pharmacy to be covered. (ontario.ca, August 18, 2026 ↗) Eligibility: Individual annual net income threshold Program year August 1, 2026 to July 31, 2027: $25,480 This applies to a senior who: does not have a spouse has a married spouse with whom they no longer live in a conjugal relationship has a spouse living in a long-term care home or community home for opportunity (ontario.ca, July 2, 2026 ↗) Eligibility: Combined annual net income requirement Program year August 1, 2026 to July 31, 2027: $42,290 This applies to a senior who has a spouse, other than a spouse described. (ontario.ca, July 2, 2026 ↗) Eligibility: See the first-year deductible table. (ontario.ca, August 18, 2026 ↗) What it pays / costs: the first $100 of total prescription costs each program year (August 1 to July 31 the following year) (ontario.ca, August 18, 2026 ↗) What it pays / costs: up to $6.11 for each prescription filled or refilled (after paying the deductible) (ontario.ca, August 18, 2026 ↗) What it pays / costs: Seniors enrolled in the Seniors Co-Payment Program have no annual deductible and a reduced co-payment of up to $2. (ontario.ca, August 18, 2026 ↗) Enrolment: "We will send you a letter about 3 months before your 65th birthday to let you know you will automatically join the Ontario Drug Benefit program on the first day of the month after you turn 65 years old." (ontario.ca, August 18, 2026 ↗) Enrolment: "To enroll in the Seniors Co-Payment Program, a senior must submit an application to that program and qualify under certain income eligibility thresholds." (ontario.ca, August 18, 2026 ↗)
First year on ODB? The deductible depends on birth month
For your first year of Ontario Drug Benefit program eligibility, depending on the month you turn 65, the deductible may be lower than $100. That’s because the amount of the deductible is based on the number of months between your official start date (the first day of the month after you turn 65) and July 31 (the last day of the Ontario Drug Benefit program year). For example, if you turned 65 on April 15, your official start date would be May 1. Counting from May 1 to July 31 your deductible for the first year would be $25. Use this chart below to see what the deductible will be in your first year:
Month you were bornAmount of first-year deductible
July$100.00
August$91.67
September$83.33
October$75.00
November$66.67
December$58.33
January$50.00
February$41.67
March$33.33
April$25.00
May$16.67
June$8.33

Ontario source · 2026-08-18